Ozempic, Wegovy and other GLP-1 drugs have been shown to curb alcoholism, a new study suggests. Researchers explain why ...
Scientists from the University of Copenhagen say they have developed a drug that decreases appetite while increasing calorie ...
Amgen said on Wednesday there was no link between its experimental weight-loss drug and changes in bone density, a day after ...
SUMMT has shown for the first time that a drug can reduce major heart failure clinical outcomes in patients with heart ...
Prachi Patkee and other analysts at Swiss Re offer that comfort to insurers, employers and patients in a new report on the impact of the new anti-obesity drugs on the insurance sectors.
After a research note raised potential safety concerns with Amgen's lead obesity candidate, the company defended its drug and ...
A new joint study by the University of Eastern Finland and Karolinska Institutet in Sweden found that the GLP-1 agonists ...